CAMBRIDGE, Mass.--(BUSINESS WIRE)--Universal DX (“UDX”), a biotech company dedicated to transforming cancer into a curable disease by detecting it early, today announced closure of the Series B which ...
-- SIGNAL-AA Part B exceeded target enrollment based on demand from patients; trial size increased to 33 patients -- WALTHAM, Mass., Oct. 21, 2025 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio ...
Nishit Agarwal exemplifies excellence in Biomedical AI and Signal Processing with extensive experience in developing cutting-edge clinical AI solutions and biomarker development. His expertise spans ...
Ulrik brings extensive experience from the pharmaceutical and data science sectors, having previously held Director level positions at Novo Nordisk, working in Denmark and Japan, and as a data ...
Advances in molecular diagnostics have driven multiplex biomarker detection as a critical approach for enhanced diagnostic ...
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ...
Oklahoma Gas and Electric (OG&E) customers will see a reduction in their monthly bills starting November 1st, thanks to a change in the fuel factor charge. Less than 24 hours after BetterWay Adult Day ...
Mercy BioAnalytics, Inc., a pioneer in blood-based detection of early-stage cancer, today announced data from a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback